Filter by: patients
What is Sleep aids?

In general, sleep medications are most effective as a temporary aid, not a long term solution. For chronic insomnia, a good sleep environment, relaxation, and behavioral techniques provide relief without risk of medication side effects or tolerance.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Sleep problems 7 1 Efficacy_slight
Inability to sleep 4 0
Insomnia 2 1 Efficacy_major
Migraine 1 0
Other 1 0

See all 14 patients currently taking Sleep aids

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
2

Reported Dosages

  1cap(s) as needed 1other as needed 50mg as needed daily 2 mg daily 5 g daily 10 mg daily 20 mg daily 25 mg daily 50 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Sleep aids (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 100%
Expense 1   Expense: 50%
Other 1   Other: 50%

See all 2 patients who’ve stopped taking Sleep aids

Currently Taking Sleep aids

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Sleep aids

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Sleep aids

Always
0 0%
Usually
1 50%
Sometimes
1 50%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Sleep aids

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

Cost of Sleep aids

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

Report created on May 27, 2012.